Physician profile
Jason Mcaloon
NPI 1760005268
$4,494.00
in general payments reported to CMS, 2019-2025
11 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what 80% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.69 · 2023: $154 · 2024: $2,828 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,049 · Grant: $2,000 · Travel and Lodging: $238 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.10 |
| Grant | $2,000.00 |
| Travel and Lodging | $238.26 |
| Education | $156.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,688.83 | 2024-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $571.43 | 2024-2025 | Intracept Rf Probe, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $546.97 | 2025 | Proclaim, Eterna |
| Abbvie INC. | $173.21 | 2022-2025 | |
| Intuitive Surgical, INC. | $134.60 | 2025 | |
| Spr Therapeutics, INC | $93.93 | 2025 | Sprint Pns System |
| Spinal Simplicity, LLC | $90.46 | 2025 | Ha Minuteman G3-R |
| Merz Pharmaceuticals, LLC | $59.24 | 2023 | Xeomin |
| Mml US, INC. | $53.52 | 2023 | Reactiv8 |
| Stryker Corporation | $50.35 | 2025 | Spinejack, Mild Device Kit |
| Ipsen Biopharmaceuticals, INC | $31.46 | 2023-2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Mcaloon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.